Piper Sandler Initiates Coverage on Beta Bionics (NASDAQ:BBNX)
Piper Sandler started coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $26.00 price target on the stock. Piper Sandler’s target price points to a potential upside of 35.63% from the stock’s current price. Several other […]
Piper Sandler started coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $26.00 price target on the stock. Piper Sandler’s target price points to a potential upside of 35.63% from the stock’s current price. Several other […]